Last updated: April 29, 2025
Sponsor: Cedars-Sinai Medical Center
Overall Status: Completed
Phase
4
Condition
N/ATreatment
Oral Contraceptive Pill, norethindrn a-e estradiol-iron
Clinical Study ID
NCT04899778
Pro00000922
Ages > 18 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Female
18 years of age or older
Currently playing basketball, soccer, or volleyball at Loyola Marymount orPepperdine
If not currently on COC, regular menstrual cycle occurring every 21-35 days
Exclusion
Exclusion Criteria:
Previous ACL injury
Underlying neuromuscular disease
Medical contraindication to COC use
History of pregnancy
Desire to conceive in the next year
Study Design
Total Participants: 73
Treatment Group(s): 1
Primary Treatment: Oral Contraceptive Pill, norethindrn a-e estradiol-iron
Phase: 4
Study Start date:
September 29, 2021
Estimated Completion Date:
June 30, 2024
Connect with a study center
Cedars Sinai Medical Center
Los Angeles, California 90048
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.